Brief: Kuros Biosciences: Expands License Agreement With Checkmate
Jan 8 (Reuters) - KUROS BIOSCIENCES AG KURN.S :
* EXPANDS LICENSE AGREEMENT WITH CHECKMATE
* KUROS BIOSCIENCES - AMENDMENT EXTENDS FIELD FROM ONCOLOGY
TO ALL
INDICATIONS AND BROADENS RANGE OF PRODUCT CANDIDATES COVERED
Source text for Eikon: ID:nTENcchxpa
Further company coverage: KURN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million